Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ANIKA THERAPEUTICS, INC.”

9 pharma patents match "ANIKA THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "ANIKA THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “ANIKA THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 11541075

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    ANIKA THERAPEUTICS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  2. US 10441677

    Methods and compositions for treating tendon degeneration

    ANIKA THERAPEUTICS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  3. US 8323617

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    ANIKA THERAPEUTICS, INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  4. US 8124120

    Crosslinked hyaluronic acid compositions for tissue augmentation

    ANIKA THERAPEUTICS, INC. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  5. US 6884788

    Thiol-modified hyaluronan

    ANIKA THERAPEUTICS, INC. · Granted Apr 26, 2005 · Expires Apr 21, 2025

    expired
  6. US 6620927

    Thiol-modified hyaluronan

    ANIKA THERAPEUTICS, INC. · Granted Sep 16, 2003 · Expires Sep 11, 2023

    expired
  7. US 6548081

    Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers

    ANIKA THERAPEUTICS, INC. · Granted Apr 15, 2003 · Expires Apr 10, 2023

    expired
  8. US 6537979

    Water-insoluble derivatives of hyaluronic acid crosslinked with a biscarbodiimide

    ANIKA THERAPEUTICS, INC. · Granted Mar 25, 2003 · Expires Mar 20, 2023

    expired
  9. US 6096727

    Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide

    ANIKA THERAPEUTICS, INC. · Granted Aug 1, 2000 · Expires Jul 27, 2020

    expired